In the past decade, immediate hypersensitivity to latex has been accep
ted as a serious problem. The proteins that are present in natural rub
ber are considered to be the responsible antigens, and the hypersensit
ivity responses induced include contact and generalized urticaria, ang
ioedema, rhinitis, conjunctivitis, bronchospasm, life threatening anap
hylaxis and death. So far, children with spina bifida or severe urogen
ital defects, health care workers, and rubber industry employees appea
r to be at greater risk than the general population. Since 1991 severa
l reports and cross-reactivity studies have demonstrated an associatio
n between latex allergy and allergy to certain fruits, especially bana
na, avocado and kiwi. Because our knowledge of the major allergens is
still incomplete, standardised in vitro and in vivo tests are not yet
readily available. Therefore, the clinician should rely on a medical h
istory, physical examination, and reliable serological tests to confir
m diagnosis of latex anaphylaxis. Because of possible systemic reactio
ns to skin prick testing and provocation tests, these methods should b
e restricted to patients with a compelling history and an-inconclusive
serologic test result. Preventive measures are the key to succesful a
nd safe management of patients with latex anaphylaxis.